Doctor profile · Federal record

Dr. Ashley Brown, MD

Dermatology Physician (CMS: Dermatology) · Louisville, KY

  • NPI 1376962860
  • Accepts Medicare
  • MIPS 62.1 / 100 · 2023
  • 12 yrs in practice
  • Female
  • Group practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
3810 Springhurst Blvd Ste 200
Louisville, KY 402416162
(502) 583-1749
fax (502) 329-8184
Additional location
1120 15Th St Fl 5
Augusta, GA 309120004
(706) 721-6231
Mailing address
Po Box 950132
Louisville, KY 402950132

Credentials & registration

NPPES · NUCC
NPI registered
April 2014 — 12 yrs on file
Profile last updated
July 17, 2018
Year of graduation
2014 — 12 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Kentucky #51075
Medicaid
KY #7100295380

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1376962860. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
5,974
Distinct HCPCS
10
Medicare allowed
$150,035
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 3,400 15 $2
17003 Destruction of precancer skin growth, 2-14 growths 782 136 $6
99213 Established patient office or other outpatient visit, 20-29 minutes 370 317 $84
17110 Destruction of skin growth, 1-14 growths 305 234 $102
17000 Destruction of precancer skin growth, 1 growth 281 209 $50
99214 Established patient office or other outpatient visit, 30-39 minutes 200 143 $117
99212 Established patient office or other outpatient visit, 10-19 minutes 132 117 $52
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 104 28 $1
99203 New patient office or other outpatient visit, 30-44 minutes 95 95 $104
11102 Biopsy of related skin growth, first growth 89 83 $85

In context: peer comparison

Among 16 peers in this city , average services per provider: 314. This provider delivers 19× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,453
Transactions
135
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
ABBVIE INC. 33 $475.57
UCB, Inc. 18 $370.57
GENZYME CORPORATION 15 $225.82
Amgen Inc. 10 $214.22
Novartis Pharmaceuticals Corporation 15 $190.86
Regeneron Healthcare Solutions, Inc. 10 $170.47
Dermavant Sciences, Inc. 5 $101.20
Incyte Corporation 4 $93.26
SUN PHARMACEUTICAL INDUSTRIES INC. 4 $88.65
Lilly USA, LLC 5 $85.61
LEO Pharma Inc. 4 $71.99
E.R. Squibb & Sons, L.L.C. 3 $64.25
Janssen Biotech, Inc. 3 $62.42
Galderma Laboratories, L.P. 3 $52.41
Arcutis Biotherapeutics, Inc. 3 $47.66

By nature of payment

Food and Beverage
$2,445
Education
$8

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
959
Patients
479
Total drug cost
$28,651
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 175 84 $12,294
Triamcinolone Acetonide Generic 146 99 $985
Hydrocortisone Generic 121 79 $670
Ketoconazole Generic 121 69 $2,750
Doxycycline Monohydrate Generic 100 38 $2,400
Clindamycin Phosphate Generic 63 29 $2,870
Mupirocin Generic 59 39 $621
Spironolactone Generic 33 0 $574
Hydroxyzine Hcl Generic 24 13 $302
Doxycycline Hyclate Generic 23 0 $693

Frequently asked questions

Auto-generated from federal data
What is Dr. Ashley Brown's medical specialty?
Dr. Ashley Brown practices Dermatology Physician in Louisville, KY.
Where does Dr. Ashley Brown practice?
Dr. Ashley Brown practices at 3810 Springhurst Blvd Ste 200, Louisville, KY 402416162. Office phone: 5025831749.
What is Dr. Ashley Brown's NPI?
Dr. Ashley Brown's National Provider Identifier (NPI) is 1376962860, issued by NPPES.
Does Dr. Ashley Brown accept Medicare assignment?
Yes. Dr. Ashley Brown accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ashley Brown commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.